Inovio Pharmaceuticals, Inc.

INO · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$107-$135-$280-$304
Dep. & Amort.$3$4$5$5
Deferred Tax$0-$0$4$0
Stock-Based Comp.$7$11$23$26
Change in WC-$3-$10$20$50
Other Non-Cash-$4$6$12$7
Operating Cash Flow-$104-$124-$216-$216
Investing Activities
PP&E Inv.$0-$0-$1-$1
Net Acquisitions$0$6-$2$0
Inv. Purchases-$54-$203-$249-$349
Inv. Sales/Matur.$159$285$361$175
Other Inv. Act.-$0$0$0$0
Investing Cash Flow$104$87$110-$175
Financing Activities
Debt Repay.-$16$0$0$0
Stock Issued$36$5$83$209
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$32-$0-$1$2
Financing Cash Flow$51$5$82$211
Forex Effect$0-$0-$0-$0
Net Chg. in Cash$52-$32-$25-$180
Supplemental Information
Beg. Cash$14$46$71$251
End Cash$66$14$46$71
Free Cash Flow-$105-$125-$217-$217